Reusable tourniquets for blood sampling as a source of multi-resistant organisms- a systematic review.
MRO
Staphylococcus aureus
cross infection
infectious disease
nosocomial infection
pathogen
tourniquet
Journal
Frontiers in public health
ISSN: 2296-2565
Titre abrégé: Front Public Health
Pays: Switzerland
ID NLM: 101616579
Informations de publication
Date de publication:
2023
2023
Historique:
received:
14
07
2023
accepted:
16
10
2023
medline:
1
12
2023
pubmed:
29
11
2023
entrez:
29
11
2023
Statut:
epublish
Résumé
The use of reusable tourniquets is widespread around the world, and reports suggest they may be overused. Several studies have shown that reusable tourniquets can affect the spread of pathogens between patients. Based on available studies, this review aims to analyse the indirect transmission of antimicrobial-resistant pathogens present on blood collection tourniquets, which may spread infectious diseases between patients in daily clinical practice. A systematic review of the literature was conducted according to the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analysis) protocol guidelines. The contents of PubMed, EBSCO (electronic databases), and Scopus were screened. Keywords used in the search included: "tourniquet," "cross infection," "nosocomial infection," " The proportional observation based on the number sampled median was 77. The genus MRSA was the type of bacteria most commonly found: on 12% of all tested tourniquets. The amount of MRSA found on tourniquets was mean ± SD 14.6 ± 45.89. A review of studies also revealed the presence of Patient safety may be at risk due to elevated contamination rates of reusable tourniquets. The microorganisms responsible for this contamination include a variety of species, the most common being the genus
Identifiants
pubmed: 38026360
doi: 10.3389/fpubh.2023.1258692
pmc: PMC10679713
doi:
Types de publication
Systematic Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
1258692Informations de copyright
Copyright © 2023 Szymczyk, Månsson and Mędrzycka-Dąbrowska.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Scand J Clin Lab Invest. 2018 Sep;78(5):417-420
pubmed: 29888620
BMC Infect Dis. 2020 Mar 26;20(1):247
pubmed: 32216761
Med J Aust. 2011 Sep 5;195(5):276-9
pubmed: 21895597
J Hosp Infect. 2007 Feb;65(2):173-5
pubmed: 17174441
J Hosp Infect. 2001 Sep;49(1):59-61
pubmed: 11516188
Postgrad Med J. 2012 Apr;88(1038):194-7
pubmed: 22298685
Acta Biomed. 2021 Dec 22;92(S2):e2021361
pubmed: 35037641
J Infect Prev. 2015 Nov;16(6):262-265
pubmed: 28989441
Med J Aust. 2002 Mar 18;176(6):286-91
pubmed: 11999266
Int J Prev Med. 2014 Sep;5(9):1119-24
pubmed: 25317294
Clin Chem Lab Med. 2018 Jul 26;56(8):e201-e203
pubmed: 29432201
Clin Lab Sci. 2010 Summer;23(3):151-6
pubmed: 20734887
Lancet. 2000 Jan 1;355(9197):44
pubmed: 10615896
J Med Eng Technol. 2009;33(6):475-80
pubmed: 19517293
Infect Control Hosp Epidemiol. 1999 Jun;20(6):408-11
pubmed: 10395142
N Engl J Med. 1986 Aug 21;315(8):514-5
pubmed: 3637628
Ceylon Med J. 2018 Mar 31;63(1):5-10
pubmed: 29754478
J Hosp Infect. 2006 Aug;63(4):428-31
pubmed: 16759742